Two routine deltoid injections, one rare shoulder complication, and differences across vaccine formulations that may hint at ...
With flu season off to an early start in the U.S., and COVID not far behind, Harvard Chan School epidemiologist Bill Hanage shares his thoughts on this year’s vaccines.
The LP.8.1-adapted BNT162b2 COVID-19 vaccine elicited a strong immune response and showed an acceptable safety profile in high-risk patients.
The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...
Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. This voice experience is generated by AI. Learn more. This voice ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA recently approved updated 2026-2027 COVID-19 vaccines from Moderna, Pfizer-BioNTech, ...
Both the seasonal flu vaccine and the updated COVID-19 vaccine are recommended annually for nearly everyone ages 6 months and older to prevent severe respiratory illness, hospitalizations, and death.
FLINTLOCK Phase 2 clinical trial will evaluate the safety, tolerability, pharmacokinetics, and clinical efficacy of high-dose monoclonal antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results